Cite
HARVARD Citation
Guo, B. et al. (2019). A utility‐based Bayesian phase I–II design for immunotherapy trials with progression‐free survival end point. Journal of the Royal Statistical Society. 68 (2), pp. 411-425. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guo, B. et al. (2019). A utility‐based Bayesian phase I–II design for immunotherapy trials with progression‐free survival end point. Journal of the Royal Statistical Society. 68 (2), pp. 411-425. [Online].